3-ethyl-5-methyl-N-(4-(piperidin-1-yl)phenethyl)-1H-indole-2-carboxamide

ID: ALA5287016

Max Phase: Preclinical

Molecular Formula: C25H31N3O

Molecular Weight: 389.54

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCc1c(C(=O)NCCc2ccc(N3CCCCC3)cc2)[nH]c2ccc(C)cc12

Standard InChI:  InChI=1S/C25H31N3O/c1-3-21-22-17-18(2)7-12-23(22)27-24(21)25(29)26-14-13-19-8-10-20(11-9-19)28-15-5-4-6-16-28/h7-12,17,27H,3-6,13-16H2,1-2H3,(H,26,29)

Standard InChI Key:  HXOQBWYSGHJGAI-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   -4.7030   -0.2475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9884    0.1647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2765   -0.2471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2765   -1.0722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9867   -1.4840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7030   -1.0759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4918   -1.3272    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4918    0.0078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0068   -0.6597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2782    0.8048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4811    1.0184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1816   -0.6597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7690    0.0548    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7690   -1.3744    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0561    0.0548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4687    0.7694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2939    0.7694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7067    1.4840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5294    1.4833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9421    0.7684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5330    0.0565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7082    0.0517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4176    0.1651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7673    0.7684    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1799    1.4830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0051    1.4830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4176    0.7684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0051    0.0537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1799    0.0537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  4  7  1  0
  3  8  1  0
  8  9  2  0
  9  7  1  0
  8 10  1  0
 10 11  1  0
  9 12  1  0
 12 13  1  0
 12 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 18 17  2  0
 19 18  1  0
 20 19  2  0
 21 20  1  0
 22 21  2  0
 17 22  1  0
  1 23  1  0
 24 20  1  0
 24 25  1  0
 26 25  1  0
 27 26  1  0
 28 27  1  0
 24 29  1  0
 29 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5287016

    ---

Associated Targets(Human)

MCF-10A (2462 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem Cyclin-dependent kinase 2 (9050 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PANC-1 (6144 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 389.54Molecular Weight (Monoisotopic): 389.2467AlogP: 5.00#Rotatable Bonds: 6
Polar Surface Area: 48.13Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 5.46CX LogP: 5.51CX LogD: 5.50
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.62Np Likeness Score: -1.07

References

1. Mohamed FAM, Alakilli SYM, El Azab EF, Baawad FAM, Shaaban EIA, Alrub HA, Hendawy O, Gomaa HAM, Bakr AG, Abdelrahman MH, Trembleau L, Mohammed AF, Youssif BGM..  (2023)  Discovery of new 5-substituted-indole-2-carboxamides as dual epidermal growth factor receptor (EGFR)/cyclin dependent kinase-2 (CDK2) inhibitors with potent antiproliferative action.,  14  (4): [PMID:37122549] [10.1039/d3md00038a]

Source